Tonix Pharmaceuticals Q3 Revenue Jumps on TONMYA Sales
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automati…
Story updates
12:23:25 PM UTC
SquawkNews
Tonix Pharmaceuticals reported third-quarter 2026 net product revenue of $17.2 million, up from $3.3 million a year earlier, including $15.0 million from TONMYA. The company recorded a net loss of $53.3 million, or $2.89 per diluted share. It ended the quarter with $162.8 million in cash and cash e…
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automati…